Where the wild things are [0.03%]
野东西在哪里
Tom Shuker
Tom Shuker
Genomics and precision medicine: The expanding role of general practitioners [0.03%]
基因组学和精准医疗：全科医生角色的扩展
Mehrnoush Bonakdar Tehrani,Janette Hayward,Talia Gusen et al.
Mehrnoush Bonakdar Tehrani et al.
Background: Precision medicine tailors an individual's healthcare to their genetics, environment and behaviour. This has been driven by rapid advances in genomics, where an individual's entire genetic code can now be sequ...
General practitioners' experiences of voluntary assisted dying in Queensland [0.03%]
昆士兰全科医生自愿辅助死亡的经历
Laura Ley Greaves,Rachel Feeney,Lindy Willmott et al.
Laura Ley Greaves et al.
Background and objectives: Voluntary assisted dying (VAD) is lawful in all Australian states, and doctors are an integral part of the VAD process. There are limited reports so far on general practitioners' (GPs') experien...
The role of general practitioners in managing patient participation in the National Bowel Cancer Screening Program: A qualitative study [0.03%]
全科医师在管理患者参与全国大肠癌筛查计划中的作用：定性研究
Caroline Bulsara,Diane Arnold-Reed,Jane Gaspar et al.
Caroline Bulsara et al.
The Australian National Bowel Cancer Screening Program (NBCSP) targets early detection through immunochemical faecal occult blood test (iFOBT) screening of eligible individuals. This study examined Western Australian general practitioner (G...
Naltrexone: A safe and effective standard of care in treating alcohol use disorder [0.03%]
纳曲酮：安全有效的治疗酒精使用障碍的常规手段
Cliff Deyo,Dean Membrey,Katherine M Conigrave et al.
Cliff Deyo et al.
Background: Harmful alcohol consumption is a common presentation in primary care. Naltrexone is a safe and effective treatment for alcohol use disorder (AUD) that remains underused because of prescriber unfamiliarity, inc...
Psychedelic-assisted psychotherapy: The Australian and general practice perspective [0.03%]
psychedelia辅助心理治疗：澳大利亚和全科医生的视角
Anthony Helman
Anthony Helman
Background: Since Australia's Therapeutic Goods Administration down-scheduled two psychedelic medicines from July 2023, psychotherapeutic treatment using these medicines has become available in the private sector, making ...